Galanis, E., Markovic, S. N., Suman, V. J., Nuovo, G. J., Vile, R. G., Kottke, T. J., . . . Kendra, K. (2012). Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. Nature Publishing Group.
Stile di citazione ChicagoGalanis, Evanthia, et al. Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients With Metastatic Melanoma. Nature Publishing Group, 2012.
Citazione MLAGalanis, Evanthia, et al. Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients With Metastatic Melanoma. Nature Publishing Group, 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.